Advertisements

Stocking Stuffers

 

DiaMedica Inc. (DMA:CA) Stock Quote

Detailed Quote for Diamedica Therapeutics Inc. (DMA:CA)
$ N/A N/A (N/A) Volume: 0 N/A
Today 5d 1m 3m 1y more
Last Price
N/A
Change $
N/A
Change %
N/A
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
N/A
High
N/A
Low
N/A
Prev Close
N/A
Last Trade
N/A
Volume
0
52 Wk Hi
18.00
52 Wk Low
3.32999992
Market Cap
N/A
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
11,956,874
EPS (TTM)
N/A
PE Ratio
N/A
Exchange
TSXV
News and Media for Diamedica Therapeutics Inc. (DMA:CA)
Sector News | Topic News
News for Diamedica Therapeutics Inc. (DMA:CA)
Tue, Apr 30, 2019
4:58 PM DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting - GlobeNewswire
Tue, Mar 19, 2019
4:30 PM DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update - GlobeNewswire
Mon, Mar 18, 2019
1:56 PM DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call - GlobeNewswire
Tue, Mar 12, 2019
1:00 PM DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019 - GlobeNewswire
Thu, Feb 14, 2019
8:00 AM DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease - GlobeNewswire
Tue, Jan 22, 2019
7:45 AM DiaMedica Therapeutics Announces Publication of a Paper, "Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke," in the Journal Therapeutic Advances in Neurological Disorders - GlobeNewswire
Wed, Jan 09, 2019
5:00 PM DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange - GlobeNewswire
Fri, Jan 04, 2019
7:45 AM Today's Research Reports on TSO3, Emerald Health Therapeutics, DiaMedica Therapeutics and Nuvo Pharmaceuticals - ACCESSWIRE IA
Thu, Jan 03, 2019
10:40 AM UPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease - GlobeNewswire
7:30 AM DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease - GlobeNewswire
Fri, Dec 21, 2018
3:02 PM DiaMedica Therapeutics Rises After Nasdaq Listing Announcement - MicroSmallCap
Tue, Dec 11, 2018
5:29 PM DiaMedica Closes Public Offering in the United States - GlobeNewswire
Fri, Dec 07, 2018
7:00 AM DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING - GlobeNewswire
Wed, Nov 21, 2018
7:45 AM Today's Research Reports on Microbix Biosystems, Hemostemix, DiaMedica Therapeutics and Nuvo Pharmaceuticals - ACCESSWIRE IA
Mon, Nov 12, 2018
4:45 PM DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation - GlobeNewswire
Tue, Nov 06, 2018
5:00 PM DiaMedica Therapeutics Announces Results From Annual General and Special Meeting of Shareholders - GlobeNewswire
Thu, Oct 25, 2018
8:00 AM Today's Research Reports on CardioComm Solutions, Sernova, Hemostemix and DiaMedica Therapeutics - ACCESSWIRE IA
Thu, Sep 27, 2018
8:52 AM DiaMedica Therapeutics and Ahon Pharma, a Fosun Pharma Portfolio Company, Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke - GlobeNewswire
Tue, Sep 18, 2018
8:00 AM Today's Research Reports on Hemostemix, TSO3, Emerald Health Therapeutics and DiaMedica Therapeutics - ACCESSWIRE IA
Wed, Sep 05, 2018
8:00 AM DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer - GlobeNewswire
More News for DMA:CA >>

Tags for DiaMedica Inc.

Research stocks or mutual funds related to DiaMedica Inc. by keywords or tags. Find companies that have a similar focus to DMA:CA. The keywords below have been associated to DMA:CA by either user submission or electronic means.

Pharmaceutical and Medicine Manufacturing (325410) Drugs Pharmaceutical and Medicine Industry (3741) Healthcare Common Stock